Vision & Mission
Clients & Associates
News & Events
R & D Center
Life at Rusan
Scholorships / Interships
General Enquiry / Send Complaints
Rusan Pharma Ltd. incorporated by chairman Dr. Navin Saxena
Inauguration of Research & Development Centre at Rusan's Head Quarter in Mumbai
Rusan Pharma Ltd bags an award for Excellence in Productivity, Quality and Innovation.
Chairman, Dr. Navin Saxena receives "Udyog Ratna" Award from Government of India.
Bulk Drug Manufacturing unit acquired in Ankleshwar, Gujarat
Rusan Pharma Ltd acquires Novartis factory in Kandla Special Economic Zone, Gandhidham, Gujarat.
Rusan Pharma Ltd receives "Chemexcil Award" for Outstanding Export Performance.
Rusan Pharma Ltd Bags Excellence Award from CHEMEXCIL.
Rusan Pharma Ltd starts the concept of
in Ukraine in collaboration with
Inaguration of Rusan Pharma's Kandla formulation facility
WHO-GMP accreditation for formulation manufacturing facility in Kandla, received.
Research Centre at Mumbai approved by Ministry of Science and Technology, Government of India.
accreditation for Bulk Drug manufacturing facility at Ankleshwar received.
UK- MHRA Accreditation for formulation manufacturing facility at Kandla received.
South Africa - MCC Accreditation for formulation manufacturing facility at Kandla received.
Zimbabwe - MCAZ accreditation for formulation manufacturing facility at Kandla received.
for Buprenorphine Hydrochloride received from EDQM.
Rusan makes entry into regulated market of UK and South Africa through the supply of Generics.
Sudan - MOH Accreditation for formulation manufacturing facility at Kandla received.
Rusan Pharma Ltd Exports more than 100 formulation to UK,South Africa, CIS, Asia.
UAE - MOH Accreditation for formulation manufacturing facility at Kandla received.
Uganda-NDA Accreditation for formulation manufacturing facility at Kandla received.
API Plant capacity increased 5 folds, for various molecules.
Land acquired for second formulation facility at Dehradun Uttarakhand.
Renewal of UK- MHRA GMP for Kandla facility.
Rusan bags South Africa TB Tender for four drug and two drug combination.
UK - MHRA-GMP Approval for API plant in Ankleshwar, Gujarat.
for Fentanyl base received from EDQM.
for Buprunorphine base received from EDQM
accreditation for formulation manufacturing facility in Dehradun, received.
Inauguration of Dehradun Formulation facility.
COS for Naltrexone Hydrochloride received from EDQM